249 related articles for article (PubMed ID: 25478770)
1. Bridging and downstaging to transplantation in hepatocellular carcinoma.
Ettorre GM; Levi Sandri GB; Santoro R; Lepiane P; Colasanti M; Vennarecci G
Future Oncol; 2014 Nov; 10(15 Suppl):61-3. PubMed ID: 25478770
[No Abstract] [Full Text] [Related]
2. Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation.
Kutlu R; Karatoprak S
J Gastrointest Cancer; 2020 Dec; 51(4):1157-1164. PubMed ID: 32880041
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of selective internal radiation therapy in challenging cases of liver-predominant unresectable hepatocellular carcinoma.
Malfertheiner P; Verslype C; Kolligs FT; Schütte K; Vandecaveye V; Paprottka PM; Ricke J
Future Oncol; 2014 Nov; 10(15 Suppl):17-27. PubMed ID: 25478762
[No Abstract] [Full Text] [Related]
4. How does selective internal radiation therapy compare with and/or complement other liver-directed therapies.
Bargellini I
Future Oncol; 2014 Nov; 10(15 Suppl):105-9. PubMed ID: 25478780
[No Abstract] [Full Text] [Related]
5. The Role of Radioembolization in Bridging and Downstaging Hepatocellular Carcinoma to Curative Therapy.
Titano J; Voutsinas N; Kim E
Semin Nucl Med; 2019 May; 49(3):189-196. PubMed ID: 30954184
[TBL] [Abstract][Full Text] [Related]
6. Downstaging to Liver Transplant: Success Involves Choosing the Right Patient.
Zhou K; Mehta N
Clin Liver Dis; 2020 Nov; 24(4):665-679. PubMed ID: 33012452
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based integration of selective internal radiation therapy into hepatocellular carcinoma management.
Sangro B
Future Oncol; 2014 Nov; 10(15 Suppl):7-11. PubMed ID: 25478760
[No Abstract] [Full Text] [Related]
8. Downstaging of bilobar hepatocellular carcinoma after radioembolization with
Reguera-Berenguer L; Orcajo-Rincón J; Rotger-Regí A; Matilla-Peña AM; Echenagusia-Boyra M; Pérez-Pascual R; Marí-Hualde A; Alonso-Farto JC
Rev Esp Med Nucl Imagen Mol; 2017; 36(5):329-332. PubMed ID: 28268101
[TBL] [Abstract][Full Text] [Related]
9. Radioembolization for hepatocellular carcinoma.
Sangro B; Iñarrairaegui M; Bilbao JI
J Hepatol; 2012 Feb; 56(2):464-73. PubMed ID: 21816126
[TBL] [Abstract][Full Text] [Related]
10. What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?
Dirican A; Karakas S
J Gastrointest Cancer; 2020 Dec; 51(4):1148-1151. PubMed ID: 32839945
[TBL] [Abstract][Full Text] [Related]
11. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
[TBL] [Abstract][Full Text] [Related]
12. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
[TBL] [Abstract][Full Text] [Related]
13. The possibility of radiotherapy as downstaging to living donor liver transplantation for hepatocellular carcinoma with portal vein tumor thrombus.
Choi JY; Yu JI; Park HC; David Kwon CH; Kim JM; Joh JW; Choi GS; Park JB; Kim SJ; Lee SH; Cho WT; Lee KW; Na BG; Oh DK; Lee N; Cho CW; Lee S; Lee SK
Liver Transpl; 2017 Apr; 23(4):545-551. PubMed ID: 28133933
[No Abstract] [Full Text] [Related]
14. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
Minocha J; Salem R; Lewandowski RJ
Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
[TBL] [Abstract][Full Text] [Related]
15. The evidence for resection post-selective internal radiation therapy.
Garlipp B; Bruns CJ
Future Oncol; 2014 Nov; 10(15 Suppl):49-52. PubMed ID: 25478767
[No Abstract] [Full Text] [Related]
16. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
[TBL] [Abstract][Full Text] [Related]
17. Tumor size remains key for prediction of hepatocellular carcinoma recurrence after liver transplantation.
Earl TM; Chapman WC
Ann Surg Oncol; 2011 May; 18(5):1217-8. PubMed ID: 21327456
[No Abstract] [Full Text] [Related]
18. Liver transplantation for hepatocellular carcinoma after yttrium therapy: a case report.
Sotiropoulos GC; Hilgard P; Antoch G; Nowak KM; Ertl J; Fouzas I; Molmenti EP; Sgourakis G; Beckebaum S; Paul A; Broelsch CE; Lang H
Transplant Proc; 2008 Dec; 40(10):3804-5. PubMed ID: 19100496
[TBL] [Abstract][Full Text] [Related]
19. Downstaging Hepatocellular Carcinoma with Yttrium-90 radioembolization: resection or transplantation?
Ettorre GM; Laurenzi A; Vennarecci G
Eur J Surg Oncol; 2014 Jun; 40(6):789-90. PubMed ID: 24572481
[TBL] [Abstract][Full Text] [Related]
20. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.
Iñarrairaegui M; Pardo F; Bilbao JI; Rotellar F; Benito A; D'Avola D; Herrero JI; Rodriguez M; Martí P; Zozaya G; Dominguez I; Quiroga J; Sangro B
Eur J Surg Oncol; 2012 Jul; 38(7):594-601. PubMed ID: 22440743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
